Probiotic peanut oral immunotherapy is associated with long‐term persistence of 8‐week sustained unresponsiveness and long‐lasting quality‐of‐life improvement.
Saved in:
| Title: | Probiotic peanut oral immunotherapy is associated with long‐term persistence of 8‐week sustained unresponsiveness and long‐lasting quality‐of‐life improvement. |
|---|---|
| Authors: | Loke, Paxton1,2,3,4 (AUTHOR), Hsiao, Kuang‐Chih1,5,6 (AUTHOR), Lozinsky, Adriana Chebar1 (AUTHOR), Ashley, Sarah E.1,2,4 (AUTHOR), Lloyd, Melanie1,4 (AUTHOR), Pitkin, Sigrid1 (AUTHOR), Axelrad, Christine Jean1 (AUTHOR), Jayawardana, Kaushala S.7 (AUTHOR), Tey, Dean1,4 (AUTHOR), Su, Ee Lyn1,4 (AUTHOR), Robinson, Marnie1,4 (AUTHOR), Leung, Agnes S.Y.1,8 (AUTHOR), Dunn Galvin, Audrey9 (AUTHOR), Tang, Mimi L.K.1,2,4 (AUTHOR) mimi.tang@rch.org.au |
| Source: | Clinical & Experimental Allergy. Jun2022, Vol. 52 Issue 6, p806-811. 6p. 1 Diagram, 2 Charts. |
| Database: | Environment Complete |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 09547894 |
|---|---|
| DOI: | 10.1111/cea.14137 |
